Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

The Tobacco Epidemic

Editor(s): Loddenkemper R. (Berlin) 
Kreuter M. (Heidelberg) 
Cover

Chapter 12

Legislation and Smoking Prevention

Latif E. · Warner V.

Author affiliations

The International Union Against Tuberculosis and Lung Disease, Edinburgh, UK

Related Articles for ""

Loddenkemper R, Kreuter M (eds): The Tobacco Epidemic, ed 2, rev. and ext. Prog Respir Res. Basel, Karger, 2015, vol 42, pp 136-148

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Chapter 12

Published online: March 24, 2015
Cover Date: 2015

Number of Print Pages: 13
Number of Figures: 9
Number of Tables: 0

ISBN: 978-3-318-02656-6 (Print)
eISBN: 978-3-318-02657-3 (Online)

Abstract

Legislation has been at the forefront of public health since Victorian times. With the WHO Framework Convention on Tobacco Control (FCTC), the WHO established that legislation is the most powerful means of combating the tobacco epidemic. In this chapter, we explore why legislation is necessary and effective for reducing tobacco consumption and the premature deaths it causes. We assess the uptake and efficacy of tobacco legislation across the globe, reviewing the ‘MPOWER' measures of the WHO FCTC, outlining bold initiatives currently employed by governments and examining the characteristics of successful tobacco control laws. We also explore the challenges involved in creating, implementing and sustaining strong tobacco control legislation, challenges mainly caused by tobacco industry interference. With this chapter, we aim to give the reader a comprehensive overview of tobacco control legislation and its potential impact on the future of the tobacco control epidemic.

© 2015 S. Karger AG, Basel


References

  1. Ashton J, Ubido J: The healthy city and the ecological idea. Soc Hist Med 1991;4:173-180.
  2. Warren MD: A Chronology of State Medicine, Public Health, Welfare and Related Services in Britain 1066-1999. London, Faculty of Public Health Medicine of the Royal Colleges of Physicians of the United Kingdom, 2000.
  3. Griffiths C, Brock A: Twentieth Century Mortality Trends in England and Wales. London, Health Statistics Quarterly, Office for National Statistics, 2003.
  4. Francis DR: Why do death rates decline? NBER Digest 2002, p 3.
  5. Centers for Disease Control and Prevention: Public Health Law Program. 2013, http://www.cdc.gov/phlp/about.html (accessed April 24, 2014).
  6. World Health Organization: History of the World Health Organization Framework Convention on Tobacco Control. Geneva, WHO, 2009.
  7. World Health Organization: WHO Framework Convention on Tobacco Control. Geneva, WHO, 2003.
  8. World Health Organization: MPOWER in Action. Geneva, WHO, 2013.
  9. World Health Organization: WHO Report on the Global Tobacco Epidemic. Geneva, WHO, 2013.
  10. Mackay JM, Bettcher DM, Minhas R, Schotte K: Successes and new emerging challenges in tobacco control: addressing the vector. Tob Control 2012;21:77.
  11. Ross HZ, Shariff S, Gilmore A: Economics of Tobacco Taxation in Russia. Paris, International Union Against Tuberculosis and Lung Disease, 2008.
  12. Levy DT, Ellis JA, Mays D, Huang AT: Smoking-related deaths averted due to three years of policy progress. Bull World Health Organ 2013;91:509-518.
  13. Centers for Disease Control and Prevention: Best Practices for Comprehensive Tobacco Control Programs. Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
  14. Eriksen M, Mackay J, Ross H: The Tobacco Atlas, ed 4. Atlanta, American Cancer Society, 2012.
  15. Callinan JE, Clarke A, Doherty A, Kelleher C: Legislative smoking bans for reducing secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev 2010;4:CD005992.
  16. Jochelson K: Nanny or Steward? The Role of Government in Public Health. London, King's Fund, 2005.
  17. Moore K, Borland R, Yong HH, Siahpush M, Cummings KM, Thrasher JF, Fong GT: Support for tobacco control interventions: do country of origin and socioeconomic status make a difference? Int J Public Health 2012;57:777-786.
  18. World Health Organization: Global Progress Report on Implementation of the WHO Framework Convention on Tobacco Control. Geneva, WHO, 2012.
  19. World Health Organization: Guidelines for Implementation of Article 11 of the WHO Framework Convention on Tobacco Control. Geneva, WHO, 2008.
  20. Jackson-Morris A, Latif E: Strengthening government tobacco control in low- and middle-income countries: a ‘must-do' for lung health progress. Int J Tuberc Lung Dis 2013;17:997-1000.
  21. Joossens L, Raw M: The Tobacco Control Scale 2013 in Europe. Brussels, Association of European Cancer Leagues, 2014.
  22. Blumenfeld K: Smoke-Free Vehicles When Children Are Present. Summit, Global Advisors on Smokefree Policy, 2014.
  23. Parliament of the United Kingdom: Children and Families Act 2014 c.6. London, 2014.
  24. Parliament of Bhutan: Tobacco Control Act of Bhutan. Thimphu, 2010.
  25. Thomson G, Edwards R, Wilson N, Blakely T: What are the elements of the tobacco endgame? Tob Control 2012:21;293-295.
  26. The Scottish Government: Creating a Tobacco-Free Generation: A Tobacco Control Strategy for Scotland. Edinburgh, 2013.
  27. Government Communications Unit: Prime Minister Matti Vanhanen at the Smokless Finland in 2040 Seminar. Helsinki, Finnish Government, 2009.
  28. World Health Organization: Reducing the Appeal of Smoking - First Experiences with Australia's Plain Tobacco Packaging Law. Geneva, WHO, 2013.
  29. Wakefield MA, Hayes L, Durkin S, Borland R: Introduction effects of the Australian plain packaging policy on adult smokers: a cross-sectional study. BMJ Open 2013:3:e003175.
  30. Chantler SC: Standardised Packaging of Tobacco: Report of the Independent Review Undertaken by Sir Cyril Chantler. London, Lea, 2014.
  31. Smoking Tobacco in Australia. London, Euromonitor International, 2014.
  32. Fickling D: Philip Morris Axes Australian Cigarette Plant after 60 Years. Bloomberg News, 2014.
  33. Mapping the Tobacco Lobby in Brussels: A Smoky Business. Brussels, Corporate Europe Observatory, 2012.
  34. Callard CD, Collishaw NE: Supply-side options for an endgame for the tobacco industry. Tob Control 2013;22:i10-i13.
  35. ASH Scotland: ASH Scotland Briefing on the Plain Packaging of Tobacco Products. 2012, http://www.ashscotland.org.uk/media/4459/plainpackaging_briefing_Feb2012.pdf (accessed March 2014).
  36. Callard C, Thompson D, Collishaw N: Transforming the tobacco market: why the supply of cigarettes should be transferred from for-profit corporations to non-profit enterprises with a public health mandate. Tob Control 2005;14:278-283.
  37. The World Bank: Economics of Tobacco Control: Myths and Facts. 2011, http://web.worldbank.org/WBSITE/EXTERNAL/TOPICS/EXTHEALTHNU TRITIONANDPOPULATION/EXTETC/0,,contentMDK:20365226∼menuPK:478891∼pagePK:148956∼piPK:216618∼theSitePK:376601,00.html (accessed February 2014).
  38. Koh HK, Joossens LX, Connolly GN: Making smoking history worldwide. N Engl J Med 2007;356:1496-1498.
  39. Crosbie E, Sebrié EM, Glantz SA: Tobacco industry success in Costa Rica: the importance of FCTC article 5.3. Salud Pública Méx 2012;54:28-38.
    External Resources
  40. The Prime Minister of the Vietnam Government. Decision 47/2013/QĐ - TTg on the Establishment and Approval of the Regulations for Organization and Operation of the Fund for Prevention and Control of Tobacco Harms. Hanoi, 2013.

Article / Publication Details

First-Page Preview
Abstract of Chapter 12

Published online: March 24, 2015
Cover Date: 2015

Number of Print Pages: 13
Number of Figures: 9
Number of Tables: 0

ISBN: 978-3-318-02656-6 (Print)
eISBN: 978-3-318-02657-3 (Online)


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.